Torrent Pharmaceuticals is currently trading at Rs. 1581.40, down by 74.30 points or 4.49% from its previous closing of Rs. 1655.70 on the BSE.
The scrip opened at Rs. 1634.90 and has touched a high and low of Rs. 1634.90 and Rs. 1525.20 respectively. So far 56338 shares were traded on the counter.
The BSE group ‘A’ stock of face value Rs. 5 has touched a 52 week high of Rs. 1964.00 on 29-Mar-2019 and a 52 week low of Rs. 1282.00 on 25-May-2018.
Last one week high and low of the scrip stood at Rs. 1681.60 and Rs. 1525.20 respectively. The current market cap of the company is Rs. 27037.02 crore.
The promoters holding in the company stood at 71.25%, while Institutions and Non-Institutions held 19.14% and 9.61% respectively.
Torrent Pharmaceuticals has reported a fall of 25.45% in its net profit at Rs 164 crore for the quarter ended March 31, 2019 as compared to Rs 220 crore for the same quarter in the previous year. However, total income of the company increased by 14.53% at Rs 1,584 crore for quarter under review as compared to Rs 1,383 crore for the quarter ended March 31, 2018.
On consolidated basis, the company has reported a net loss of Rs 152 crore for the quarter ended March 31, 2019 against net profit of Rs 228 crore for the corresponding quarter in the FY18. However, total consolidated income of the company rose by 7.03% at Rs 1,873 crore for quarter under review as compared to Rs 1,750 crore for the same quarter ended previous year.
For the year ended March 31, 2019, the company has posted a rise of 54.56% in its net profit at Rs 745 crore as compared to Rs 482 crore for the previous year. Total income of company increased 34.27% at Rs 6,144 crore for year under review as compared to Rs 4,576 crore for year ended March 31, 2018.
For the year ended March 31, 2019, on the consolidated basis, the company has posted fall of 35.69% in its net profit at Rs 436 crore as compared to Rs 678 crore for the previous year. However, total income of company increased by 23.70% at Rs 7,730 crore for year under review as compared to Rs 6,249 crore for year ended March 31, 2018.
The post Torrent Pharma declines on reporting consolidated net loss of Rs 152 crore in Q4 appeared first on Udaipur News | Udaipur Latest News | udaipur local news.
